Navigation Links
Ganeden Biotech Hires New Marketing Manager
Date:12/10/2012

Cleveland, OH (PRWEB) December 10, 2012

Ganeden Biotech®, a recognized world leader in the manufacturing and marketing of probiotics, announced today that Erin Miller has joined the company as Marketing Manager.

“Erin is very digitally savvy and her keen sense and understanding of proactive marketing will help drive Ganeden’s expansion efforts in 2013 and beyond,” said Mike Bush, Vice President of Business Development, Ganeden Biotech. “Ganeden is fortunate to have Erin on its team.”

In her role as Marketing Manager, Miller will lead Ganeden Biotech’s marketing and communications efforts for its GanedenBC30 and Bonicel brands – both branded probiotic and/or probiotic-derived ingredients. Her responsibilities include overseeing public and media relations, distributor communications, advertising, website development, and tradeshow planning. She will also provide support to the Ganeden sales team by way of strategic planning, market research, direct mail and email marketing, customer communications and lead generation.

Prior to joining Ganeden Biotech, Miller spent the majority of her career in publishing, and specifically, the last eight years with Crain’s Cleveland Business as Audience Development and Retention Manager. In this role she was solely responsible for growing paid print and free digital readers for both Crainscleveland.com and Crain’s Cleveland, the print edition. She managed to grow the online subscriber base by 400 percent during the course of her tenure and was instrumental in creating a social media network.

Prior to joining Crain’s, Miller lived in New York where she held marketing positions with YM and Fitness magazines (Gruner + Jahr USA), and Primedia – Consumer Media and Magazine Group.

Miller has served prominent roles with the Cleveland Chapter of the American Marketing Association (AMA), including President where she led her chapter in winning Turnaround Chapter Of The Year, an award given by the national association.

Miller is also very involved in PAWS – Public Animal Welfare Society of Ohio. She is the current Director of Public Relations, Communications and Social Media and serves on the PAWS-4-A-Cause event planning committee.

Miller attended the Pennsylvania State University in State College, Pa., and earned a Bachelor of Science in Marketing.

###

About Ganeden Biotech
Founded in 1997, Cleveland, Ohio based Ganeden Biotech is at the forefront of probiotic research and product development. Ganeden has an extensive library of published studies and more than 100 patents for probiotic technologies for the food, beverage, animal health, and now topical ingredients markets. The company is best known for GanedenBC30®, its patented, probiotic ingredient, which is found in more than 60 leading food and beverage products. Ganeden helps manufacturers develop and market probiotic products and offers an extensive intellectual property portfolio with patent and trademark protection for an array of technologies all over the world.

For more information about Ganeden Biotech and licensing opportunities visit ganedenbiotech.com.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10223158.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Probiotic-Enriched Instant Chai Latte and Teas to be Launched by Ganeden Biotech and Tipton Mills
2. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
3. Puma Biotechnology Announces Completion of Private Placement
4. Animal Biotechnology - Technologies, Markets and Companies
5. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
6. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
7. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
8. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
9. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
10. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
11. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the ... the Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s ... how hardware projects are designed, built and brought to market. , The Design ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):